The National Institute for Health and Care Excellence (NICE) has recommended Santhera Pharmaceuticals’ Agamree (vamorolone) to treat Duchenne muscular dystrophy (DMD). The drug has been recommended ...

Regeneron Pharmaceuticals has shared positive data from a phase 3 trial of pozelimab plus cemdisiran (poze-cemdi) in patients ...

GSK and Rgenta Therapeutics have partnered to develop RNA-targeting small molecule splice modulators for disease areas ...

Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China.

Novartis will be gaining exclusive global rights to PTC Therapeutics’ mid-stage Huntington’s disease (HD) programme in a deal ...

Amgen has announced a $1bn investment to establish a second US drug substance manufacturing facility in North Carolina. The ...

Researchers from the Institute of Cancer Research (ICR) have found a way to predict how long prostate cancer patients will ...

Great Place To Work® and Fortune have ranked CMI Media Group and Compas as number 10 on the 2024 Fortune Best Workplaces in ...

Managing data effectively can be challenging in any industry. But it’s especially difficult in pharmaceuticals, which faces ...

LEO Pharma has announced that its Anzupgo (delgocitinib) cream has been approved by the Medicines and Healthcare Products ...

Amgen’s investigational antibody peptide conjugate has shown promise in a mid-stage trial of patients who are overweight or ...

To better understand how MFPs might impact payer utilization management strategies, rebate negotiations, and business ...